These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25426460)

  • 41. Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system.
    Rodríguez-Gómez JA; Venero JL; Vizuete ML; Cano J; Machado A
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):31-8. PubMed ID: 9191076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.
    Mehler-Wex C; Riederer P; Gerlach M
    Neurotox Res; 2006 Dec; 10(3-4):167-79. PubMed ID: 17197367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylphenidate administration reverts attentional inflexibility in adolescent rats submitted to a model of neonatal hypoxia-ischemia: Predictive validity for ADHD study.
    Miguel PM; Deniz BF; Confortim HD; Bronauth LP; de Oliveira BC; Alves MB; Silveira PP; Pereira LO
    Exp Neurol; 2019 May; 315():88-99. PubMed ID: 30771298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
    Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
    J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency.
    Korner G; Noain D; Ying M; Hole M; Flydal MI; Scherer T; Allegri G; Rassi A; Fingerhut R; Becu-Villalobos D; Pillai S; Wueest S; Konrad D; Lauber-Biason A; Baumann CR; Bindoff LA; Martinez A; Thöny B
    Brain; 2015 Oct; 138(Pt 10):2948-63. PubMed ID: 26276013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Animal models of attention-deficit hyperactivity disorder.
    Davids E; Zhang K; Tarazi FI; Baldessarini RJ
    Brain Res Brain Res Rev; 2003 Apr; 42(1):1-21. PubMed ID: 12668288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson's disease.
    Real CC; Ferreira AF; Chaves-Kirsten GP; Torrão AS; Pires RS; Britto LR
    Neuroscience; 2013 May; 237():118-29. PubMed ID: 23396085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
    Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Orbitofrontal Signaling of Future Reward is Associated with Hyperactivity in Attention-Deficit/Hyperactivity Disorder.
    Tegelbeckers J; Kanowski M; Krauel K; Haynes JD; Breitling C; Flechtner HH; Kahnt T
    J Neurosci; 2018 Jul; 38(30):6779-6786. PubMed ID: 29954849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemogenetic activation of dopamine neurons in the ventral tegmental area, but not substantia nigra, induces hyperactivity in rats.
    Boekhoudt L; Omrani A; Luijendijk MC; Wolterink-Donselaar IG; Wijbrans EC; van der Plasse G; Adan RA
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1784-1793. PubMed ID: 27712862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury.
    Yan HQ; Ma X; Chen X; Li Y; Shao L; Dixon CE
    Brain Res; 2007 Feb; 1134(1):171-9. PubMed ID: 17196177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgery Under General Anesthesia Alleviated the Hyperactivity but Had No Effect on the Susceptibility to PND in ADHD Rats.
    Zhang P; Xu F; Zhao G; Zhang X; Li A; Dong H; Xiong L
    Front Psychiatry; 2019; 10():642. PubMed ID: 31551833
    [No Abstract]   [Full Text] [Related]  

  • 56. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T; Rohde LA; Hutz MH
    Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder.
    Puumala T; Ruotsalainen S; Jäkälä P; Koivisto E; Riekkinen P; Sirviö J
    Neurobiol Learn Mem; 1996 Sep; 66(2):198-211. PubMed ID: 8946412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study.
    Payton A; Holmes J; Barrett JH; Hever T; Fitzpatrick H; Trumper AL; Harrington R; McGuffin P; O'Donovan M; Owen M; Ollier W; Worthington J; Thapar A
    Am J Med Genet; 2001 Jul; 105(5):464-70. PubMed ID: 11449400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic selegiline administration transiently decreases tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway.
    Vrana SL; Azzaro AJ; Vrana KE
    Mol Pharmacol; 1992 May; 41(5):839-44. PubMed ID: 1350320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The Relationship Between Emotion Recognition and the Symptoms of Attention Deficit and Impulsivity in Adult Patients With Attention Deficit Hyperactivity Disorder].
    Baran Tatar Z; Yargıç İ; Oflaz S; Büyükgök D
    Turk Psikiyatri Derg; 2015; 26(3):172-80. PubMed ID: 26364171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.